Up-regulation and trafficking of δ opioid receptor in a model of chronic inflammation: Implications for pain control

Pain

Volumn 101, Issue 1-2, 2003, Pages 199-208

  Cahill, C M ^a   Morinville, A ^a,b   Hoffert, C ^c   O'Donnell, D ^c   Beaudet, Alain ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Delta opioid receptor; Electron microscopy; Inflammation; Pain; Receptor trafficking

Indexed keywords

DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; FREUND ADJUVANT;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL MEMBRANE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DENDRITE; ELECTRON MICROSCOPY; IN SITU HYBRIDIZATION; LUMBAR SPINAL CORD; MALE; NERVE ENDING; NONHUMAN; NONMYELINATED NERVE; PERIKARYON; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION; WESTERN BLOTTING;

EID: 0037222250     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00333-0     Document Type: Article

References (38)

1. Arvidsson U., Dado R.J., Riedl M., Lee J.H., Law P.Y., Loh H.H., Elde R., Wessendorf M.W. δ-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci. 15:1995;1215-1235.
2. Besse D., Weil-Fugazza J., Lombard M.C., Butler S.H., Besson J.M. Monoarthritis induces complex changes in mu-, delta- and kappa-opioid binding sites in the superficial dorsal horn of the rat spinal cord. Eur J Pharmacol. 223:1992;123-131.
3. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
4. Cahill C.M., McClellan K.A., Morinville A., Hoffert C., Hubatsch D., O'Donnell D., Beaudet A. Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J Comp Neurol. 440:2001;65-84.
5. Cao C.Q., Hong Y., Dray A., Perkins M. Spinal delta-opioid receptors mediate suppression of systemic SNC80 on excitability of the flexor reflex in normal and inflamed rat. Eur J Pharmacol. 418:2001;79-87.
6. Cheng P.Y., Svingos A.L., Wang H., Clarke C.L., Jenab S., Beczkowska I.W., Inturrisi C.E., Pickel V.M. Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. J Neurosci. 15:1995;5976-5988.
7. Cowan A., Zhu X.Z., Mosberg H.I., Omnaas J.R., Porreca F. Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther. 246:1988;950-955.
8. Donaldson L.F. Unilateral arthritis: contralateral effects. Trends Neurosci. 22:1999;495-496.
9. Fields H.L., Basbaum A.I. Central nervous system mechanisms of pain modulation. Melzack R., Wall P.D. Textbook of Pain. 1994;243-257 Churchill-Livingstone, Edinburgh.
10. Fraser G.L., Gaudreau G.A., Clarke P.B., Menard D.P., Perkins M.N. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation. Br J Pharmacol. 129:2000;1668-1672.
11. Gaudriault G., Nouel D., Dal Farra C., Beaudet A., Vincent J.P. Receptor-induced internalization of selective peptidic μ and δ opioid ligands. J Biol Chem. 272:1997;2880-2888.
12. Hurley R.W., Hammond D.L. The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci. 20:2000;1249-1259.
13. Hylden J.L.K., Nahin R.L., Traub R.T., Dubner R. Enhancement of receptive fields of spinal lamina I projection neurons in rats with unilateral ajuvant-induced inflammation: the contribution of dorsal horn mechanisms. Pain. 37:1989;229-243.
14. Hylden J.L., Thomas D.A., Iadorola M.J., Nahin R.L., Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol. 194:1991;134-143.
15. Iadarola M.J., Douglass J., Civelli O., Naranjo J.R. Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Bain Res. 455:1988;202-212.
16. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci. 15:1995;8156-8166.
17. Kieffer B.L. Opioids: first lessons from knockout mice. Trends Pharmacol Sci. 20:1999;19-26.
18. Koltzenburg M., Wall P.D., McMahon S.B. Does the right side know what the left is doing? Trends Neurosci. 22:1999;122-127.
19. Maekawa K., Minami M., Masuda T., Satoh M. Expression of mu- and kappa-, but not delta-, opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats. Pain. 64:1995;365-371.
20. Malmberg A.B., Yaksh T.L. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). J Pharmacol Exp Ther. 263:1992;264-275.
21. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol. 350:1994;412-438.
22. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci. 7:1987;2445-2464.
23. Mason P. Central mechanisms of pain modulation. Curr Opin Neurobiol. 9:1999;436-441.
24. Mattia A., Farmer S.C., Takemori A.E., Sultana M., Portoghese P.S., Mosberg H.I., Bowen W.D., Porreca F. Spinal opioid delta antinociception in the mouse: mediation by a 5′-NTII-sensitive delta receptor subtype. J Pharmacol Exp Ther. 260:1992;518-525.
25. Mattia A., Vanderah T., Mosberg H.I., Porreca F. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. J Pharmacol Exp Ther. 258:1991;583-587.
26. May C.N., Dashwood M.R., Whitehead C.J., Mathias C.J. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution. Br J Pharmacol. 98:1989;903-913.
27. Minami M., Maekawa K., Yabuuchi K., Satoh M. Double in situ hybridization study on co-existence of μ, δ, and κ-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Mol Brain Res. 30:1995;203-210.
28. Montagne-Clavel J., Oliveras J.L. The 'plantar test' apparatus (Ugo Basile Biological Apparatus), a controlled infrared noxious radiant heat stimulus for precise withdrawal latency measurement in the rat, as a tool for humans? Somatosen Mot Res. 13:1996;215-223.
29. Porreca F., Mosberg H.I., Hurst R., Hruby V.J., Burks T.F. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther. 230:1984;341-348.
30. Qiu C., Sora I., Uhl G., Dubner R. Enhanced δ-opioid receptor-mediated antinociception in μ-opioid receptor-deficient mice. Eur J Pharmacol. 387:2000;163-169.
31. Quirion R., Zajac J.M., Morgat J.L., Rogues B.P. Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands. Life Sci. 33:1983;227-230.
32. Sharif N.A., Hughes J. Neuroanatomical mapping and quantification of peptide and drug receptors by quantitative digitial subtraction autoradiography. Sharif N.A., Lewis M.E. Brain Imaging Techniques and Applications. 1989;36-76 Halsted Press, New York, NY.
33. Sheldon R.J., Riviere P.J., Malarchik M.E., Moseberg H.I., Burks T.F., Porreca F. Opioid regulation of mucosal ion transport in the mouse isolated jejunum. J Pharmacol Exp Ther. 253:1990;144-151.
34. Stewart P.E., Hammond D.L. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. J Pharmacol Exp Ther. 266:1993;820-828.
35. Stewart P.E., Hammond D.L. Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J Pharmacol Exp Ther. 268:1994;701-708.
36. Szeto H.H., Soong Y., Wu D., Olariu N., Kett A., Kim H., Clapp J.F. Respiratory depression after intravenous administration of delta-selective opioid peptide analogs. Peptides. 20:1999;101-105.
37. Wang H., Wessendorf M.W. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J Comp Neurol. 429:2001;590-600.
38. Willis W.D., Coggeshall R.E. Sensory Mechanisms of the Spinal Cord. 2nd Ed:1991;1-100 Plenum Press, NewYork, NY.